Geographic Atrophy (GA)

Ophthalmology·MeSH: Geographic Atrophy

8 drugs in development·7 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
ANX007	Annexon, Inc. (ANNX)

Phase 2(3)

Drug	Company
JNJ-81201887	Crinetics Pharmaceuticals, Inc. (CRNX)
opregen	Lineage Cell Therapeutics, Inc. (LCTX)
Triamcinolone	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 1(1)

Drug	Company
Pozelimab	REGENERON PHARMACEUTICALS, INC. (REGN)

Preclinical(3)

Drug	Company
4D-175	4D Molecular Therapeutics, Inc. (FDMT)
ic-500	IVERIC bio, Inc. (ISEE)
szn-113	Surrozen Inc. (SRZN)

BioSniper tracks 8 drugs in development for Geographic Atrophy (GA) across 7 companies.

There are 2 clinical trials targeting Geographic Atrophy (GA) tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.